COVID-19 Management in the Brain and Body describes the management of patients with the novel coronavirus in their varied symptoms. Detailing this multisystem disease and the variety of organs and tissues affected, this volume features chapters on neurological systems, including brain cancer, brain embolism, and meningoencephalitis. Several systems are addressed, including conditions affecting hematological, hepatobiliary, gastrointestinal, and cardiovascular systems. Telemedicine and are also discussed. This volume is relevant for all clinicians working to ensure the best outcomes and patient care of patients with COVID-19.
1. Management, Body Systems, and Case Studies in COVID-19 - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iv 5. Copyright - p. Page v 6. Dedication - p. Page vi 7. Contributors - p. Page vi 8. Preface - p. Page xiii 9. List of Illustrations - p. Page xiv 10. List of Tables - p. Page xv 11. Chapter 1 : Hand hygiene strategies - p. Page xv 12. Chapter 2 : Approved vaccines for the COVID-19 pandemic: Linking in future perspectives - p. Page 10 13. Chapter 3 : Molecular methods for SARS-CoV-2 variant detection - p. Page 23 14. Chapter 4 : Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19 and other pulmonary diseases - p. Page 35 15. Chapter 5 : Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19 - p. Page 52 16. Chapter 6 : COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines - p. Page 59 17. Chapter 7 : Management of COVID-19 and clinical nutrition - p. Page 71 18. Chapter 8 : The management of head and neck cancer in COVID-19 - p. Page 84 19. Chapter 9 : The COVID-19 pandemic: Inventory management and allocation of personal protective equipment - p. Page 93 20. Chapter 10 : Clinical management in the COVID-19 pandemic: Rheumatic disease - p. Page 107 21. Chapter 11 : Managing migraines during the COVID-19 pandemic: An Italian experience - p. Page 119 22. Chapter 12 : Managing acute ischemic stroke in the SARS-CoV-2 pandemic - p. Page 131 23. Chapter 13 : Impact of the coronavirus disease 2019 pandemic on patients with hypertension - p. Page 143 24. Chapter 14 : Neurosurgical trauma management during COVID-19 restrictions - p. Page 154 25. Chapter 15 : The COVID-19 pandemic and management of weight gain: Implications for obesity - p. Page 165 26. Chapter 16 : COVID-19 and the management of heart failure using telemedicine - p. Page 172 27. Chapter 17 : Guidelines for breast imaging in the COVID-19 pandemic - p. Page 181 28. Chapter 18 : Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines, and reporting - p. Page 193 29. Chapter 19 : Lung cancer in the era of COVID-19 - p. Page 207 30. Chapter 20 : Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem syndrome: Clinical guidelines - p. Page 217 31. Chapter 21 : Ground-glass nodules in the lungs of COVID-19 patients - p. Page 229 32. Chapter 22 : Cardiothoracic imaging in patients affected by COVID-19 - p. Page 241 33. Chapter 23 : Bronchial epithelial cells in cystic fibrosis: What happens in SARS-CoV-2 infection? - p. Page 254 34. Chapter 24 : Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection - p. Page 265 35. Chapter 25 : Long noncoding RNA profiling in respiratory specimens from COVID-19 patients - p. Page 279 36. Chapter 26 : COVID-19 and acute pulmonary embolism - p. Page 291 37. Chapter 27 : The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic - p. Page 299 38. Chapter 28 : Cardiac manifestations of COVID-19: An overview - p. Page 307 39. Chapter 29 : Limb ischemia and COVID-19 - p. Page 320 40. Chapter 30 : Thrombosis and coagulopathy in COVID-19: A current narrative - p. Page 332 41. Chapter 31 : COVID-19 myocarditis: Features of echocardiography - p. Page 344 42. Chapter 32 : COVID-19 lockdown and impact on arrhythmias - p. Page 356 43. Chapter 33 : Cardiometabolic disease and COVID-19: A new narrative - p. Page 361 44. Chapter 34 : Postrecovery COVID-19 and interlinking diabetes and cardiovascular events - p. Page 372 45. Chapter 35 : COVID-19 patients and extracorporeal membrane oxygenation - p. Page 380 46. Chapter 36 : Sars-CoV-2 infection in different hematological patients - p. Page 393 47. Chapter 37 : Dermatological reactions associated with personal protective equipment use during the COVID-19 pandemic - p. Page 404 48. Chapter 38 : Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response - p. Page 419 49. Chapter 39 : Coinfections with COVID-19: A focus on tuberculosis (TB) - p. Page 426 50. Chapter 40 : Patients with autoimmune liver disease and the impact of Sars-COV-2 infection - p. Page 438 51. Chapter 41 : COVID-19 severity and nonalcoholic fatty liver disease - p. Page 452 52. Chapter 42 : Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia Commonwealth University health system - p. Page 459 53. Chapter 43 : COVID-19 associated rhino-orbital-cerebral mucormycosis in patients with diabetes and comorbid conditions - p. Page 469 54. Chapter 44 : Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health - p. Page 480 55. Chapter 45 : Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism - p. Page 490 56. Chapter 46 : Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury - p. Page 496 57. Chapter 47 : Obesity, COVID-19 severity, and mortality - p. Page 503 58. Chapter 48 : Upper and lower gastrointestinal symptoms and manifestations of COVID-19 - p. Page 515 59. Chapter 49 : The COVID-19 survivors: Impact on skeletal muscle strength - p. Page 533 60. Chapter 50 : Case study: Oral mucosal lesions in patients with COVID-19 - p. Page 549 61. Chapter 51 : Case study: COVID-19 pneumonia presented with cavitary lesions - p. Page 559 62. Chapter 52 : Case study: Optic neuritis in SARS-CoV-2 infection - p. Page 565 63. Chapter 53 : Recommended resources relevant to the body systems involvement and management of COVID-19 - p. Page 565 64. Index - p. Page 579
COVID-19 Management in the Brain and Body describes the management of patients with the novel coronavirus in their varied symptoms. Detailing this multisystem disease and the variety of organs and tissues affected, this volume features chapters on neurological systems, including brain cancer, brain embolism, and meningoencephalitis. Several systems are addressed, including conditions affecting hematological, hepatobiliary, gastrointestinal, and cardiovascular systems. Telemedicine and are also discussed. This volume is relevant for all clinicians working to ensure the best outcomes and patient care of patients with COVID-19.
1. Management, Body Systems, and Case Studies in COVID-19 - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iv 5. Copyright - p. Page v 6. Dedication - p. Page vi 7. Contributors - p. Page vi 8. Preface - p. Page xiii 9. List of Illustrations - p. Page xiv 10. List of Tables - p. Page xv 11. Chapter 1 : Hand hygiene strategies - p. Page xv 12. Chapter 2 : Approved vaccines for the COVID-19 pandemic: Linking in future perspectives - p. Page 10 13. Chapter 3 : Molecular methods for SARS-CoV-2 variant detection - p. Page 23 14. Chapter 4 : Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19 and other pulmonary diseases - p. Page 35 15. Chapter 5 : Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19 - p. Page 52 16. Chapter 6 : COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines - p. Page 59 17. Chapter 7 : Management of COVID-19 and clinical nutrition - p. Page 71 18. Chapter 8 : The management of head and neck cancer in COVID-19 - p. Page 84 19. Chapter 9 : The COVID-19 pandemic: Inventory management and allocation of personal protective equipment - p. Page 93 20. Chapter 10 : Clinical management in the COVID-19 pandemic: Rheumatic disease - p. Page 107 21. Chapter 11 : Managing migraines during the COVID-19 pandemic: An Italian experience - p. Page 119 22. Chapter 12 : Managing acute ischemic stroke in the SARS-CoV-2 pandemic - p. Page 131 23. Chapter 13 : Impact of the coronavirus disease 2019 pandemic on patients with hypertension - p. Page 143 24. Chapter 14 : Neurosurgical trauma management during COVID-19 restrictions - p. Page 154 25. Chapter 15 : The COVID-19 pandemic and management of weight gain: Implications for obesity - p. Page 165 26. Chapter 16 : COVID-19 and the management of heart failure using telemedicine - p. Page 172 27. Chapter 17 : Guidelines for breast imaging in the COVID-19 pandemic - p. Page 181 28. Chapter 18 : Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines, and reporting - p. Page 193 29. Chapter 19 : Lung cancer in the era of COVID-19 - p. Page 207 30. Chapter 20 : Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem syndrome: Clinical guidelines - p. Page 217 31. Chapter 21 : Ground-glass nodules in the lungs of COVID-19 patients - p. Page 229 32. Chapter 22 : Cardiothoracic imaging in patients affected by COVID-19 - p. Page 241 33. Chapter 23 : Bronchial epithelial cells in cystic fibrosis: What happens in SARS-CoV-2 infection? - p. Page 254 34. Chapter 24 : Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection - p. Page 265 35. Chapter 25 : Long noncoding RNA profiling in respiratory specimens from COVID-19 patients - p. Page 279 36. Chapter 26 : COVID-19 and acute pulmonary embolism - p. Page 291 37. Chapter 27 : The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic - p. Page 299 38. Chapter 28 : Cardiac manifestations of COVID-19: An overview - p. Page 307 39. Chapter 29 : Limb ischemia and COVID-19 - p. Page 320 40. Chapter 30 : Thrombosis and coagulopathy in COVID-19: A current narrative - p. Page 332 41. Chapter 31 : COVID-19 myocarditis: Features of echocardiography - p. Page 344 42. Chapter 32 : COVID-19 lockdown and impact on arrhythmias - p. Page 356 43. Chapter 33 : Cardiometabolic disease and COVID-19: A new narrative - p. Page 361 44. Chapter 34 : Postrecovery COVID-19 and interlinking diabetes and cardiovascular events - p. Page 372 45. Chapter 35 : COVID-19 patients and extracorporeal membrane oxygenation - p. Page 380 46. Chapter 36 : Sars-CoV-2 infection in different hematological patients - p. Page 393 47. Chapter 37 : Dermatological reactions associated with personal protective equipment use during the COVID-19 pandemic - p. Page 404 48. Chapter 38 : Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response - p. Page 419 49. Chapter 39 : Coinfections with COVID-19: A focus on tuberculosis (TB) - p. Page 426 50. Chapter 40 : Patients with autoimmune liver disease and the impact of Sars-COV-2 infection - p. Page 438 51. Chapter 41 : COVID-19 severity and nonalcoholic fatty liver disease - p. Page 452 52. Chapter 42 : Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia Commonwealth University health system - p. Page 459 53. Chapter 43 : COVID-19 associated rhino-orbital-cerebral mucormycosis in patients with diabetes and comorbid conditions - p. Page 469 54. Chapter 44 : Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health - p. Page 480 55. Chapter 45 : Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism - p. Page 490 56. Chapter 46 : Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury - p. Page 496 57. Chapter 47 : Obesity, COVID-19 severity, and mortality - p. Page 503 58. Chapter 48 : Upper and lower gastrointestinal symptoms and manifestations of COVID-19 - p. Page 515 59. Chapter 49 : The COVID-19 survivors: Impact on skeletal muscle strength - p. Page 533 60. Chapter 50 : Case study: Oral mucosal lesions in patients with COVID-19 - p. Page 549 61. Chapter 51 : Case study: COVID-19 pneumonia presented with cavitary lesions - p. Page 559 62. Chapter 52 : Case study: Optic neuritis in SARS-CoV-2 infection - p. Page 565 63. Chapter 53 : Recommended resources relevant to the body systems involvement and management of COVID-19 - p. Page 565 64. Index - p. Page 579
